Feasibility of dc vaccine combined with low dose endoxan and high dose il-2 treatment associated with taurolidine for advanced, multi-resistant melanoma patients.

November 2015, J Immunother Cancer. 2015; 3(Suppl 2): P209

(DOI: 10.1186/2051-1426-3-S2-P209)